info@marketfacts.ca +1-807 788 8478
Company Overview
•Ticker: GCT (NASDAQ)
•Headquarters: El Monte, California, USA
•Founded:2006 (rebranded as GigaCloud in 2019)
•CEO: Lei (Larry) Wu (as of 2025)
•Industry: B2B E-commerce & Logistics Technology
Company Overview
•Ticker: APA (NASDAQ)
•Headquarters: Houston, Texas, USA
•Founded: 1954
•CEO: John J. Christmann IV (as of 2025)
•Industry: Oil & Gas Exploration and Production
Company Overview
• Ticker: POU (TSX)
• Headquarters: Alberta, Canada
• Founded: 1976
• CEO: Jim Riddell
• Industry: Oil & Gas Production
Ticker: CCL (NYSE, LSE)
Headquarters: Miami, Florida, USA
CEO: Josh Weinstein (as of 2024)
Founded: 1972
Industry: Leisure Travel / Cruise Lines
Ticker: ON (NASDAQ)
Headquarters: Scottsdale, Arizona, USA
Founded: 1999 (spun off from Motorola)
CEO: Hassane El-Khoury (as of 2024)
Industry: Semiconductors
Gambling.com Group Limited (NASDAQ: GAMB) is a prominent performance marketing company that has carved out a significant niche within the online gambling industry by leveraging its data-driven digital marketing strategies and proprietary technology platform.
Electronic Arts Inc. (NASDAQ: EA) is a leading American video game company headquartered in Redwood City, California. Founded in 1982 by former Apple employee Trip Hawkins, EA has been a key player in the interactive entertainment industry, developing and publishing games for consoles, PCs, and mobile devices.
Ambac Financial Group, Inc. (NYSE: AMBC) is a financial services holding company that operates across multiple segments, including specialty property and casualty insurance, legacy financial guarantee management, and asset management.
Cal-Maine Foods, Inc. (NASDAQ: CALM) is the largest producer and distributor of fresh shell eggs in the United States. Founded in 1957 and headquartered in Ridgeland, Mississippi, the company supplies eggs to various retail and foodservice customers across the country. Cal-Maine operates a vertically integrated business model, managing all aspects of production, from breeding and hatching to feeding,
Anavex Life Sciences Corp. (NASDAQ: AVXL) is a clinical-stage biopharmaceutical company dedicated to developing innovative therapies for central nervous system (CNS) disorders, with a primary focus on Alzheimer’s disease, Parkinson’s disease, and Rett syndrome. The company’s proprietary SIGMACEPTOR™ platform leverages sigma-1 receptor (S1R) agonists to restore cellular homeostasis, targeting key mechanisms such as oxidative stress, inflammation, and mitochondrial dysfunction.